ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 26040 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 26040; 2) Community: the network communities that were significantly associated with the response to NSC 26040; 3) Molecule: the relationships between components within communities and NSC 26040; 4) MDR: the compounds that were significantly associated with the NSC 26040.

NSC Compound Enrichment Correlation
NSC 268251 4,6-DIDEOXY-4-[[[(14-METHYL-1-OXOPENTADECYL)AMINO]ACETYL]AMINO]-N-1H-PURIN-6-YL-.BETA.-L-GLUCOPYRANOSYLAMINE 0.0223138217461955 0.0081530706
NSC 682094 Quinolinium, 1,1'-(1,10-decanediyl)bis[(2-methyl- 4-(phenylmethylamino)-, diperchlorate 0.0223138217461955 0.037480805
NSC 698687 Null 0.0223138217461955 -0.075461205
NSC 194618 Benz[a]anthracene-7,12-dione, 1,8-dihydroxy-3-methyl- (7CI, 8CI, 9CI) 0.0244718705444135 0.23182278
NSC 363812 Tetraplatin 0.0244718705444135 0.27815276
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0244718705444135 0.30158296
NSC 380721 Eremantholide B 0.0244718705444135 0.24666028
NSC 39135 Null 0.0244718705444135 0.25234378
NSC 621335 Null 0.0244718705444135 0.37763722
NSC 621336 Null 0.0244718705444135 0.38245054
Total:64  Current:32    [First] [Prev] [Next] [Last]